Court affirms patent decision against Medtronic
This article was originally published in Clinica
Medtronic is to take a one-off charge of around $52 million, after the Federal Circuit Court of Appeal affirmed an earlier district court decision concerning a patent infringement case. The initial case, dating from late 1999, found that certain of Medtronic Sofamor Danek's spinal fixation products infringed patent held by Johnson & Johnson subsidiary AcroMed (see Clinica No 860, p 12).
You may also be interested in...
Podcast: Living In China's Coronavirus Lockdown, Novartis and England's 'Public Health' Alliance; Biogen's Moment of Truth Approaches
Japan bioventure BioComo was set up around 10 years ago and has since been honing its technology platform. It is now preparing to move into the clinic with a novel vector for immuno-oncology and to raise new funds to support pipeline development.
Several newly repurposed drugs, including a Bayer antimalarial, have shown potential benefits against the new coronavirus, promoting China to add several to its latest revised treatment guidelines.